3 Recruiting Studies Using Nxp900
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Nxp900
🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
📍 Mayo Clinic — Phoenix, Arizona
Advanced Solid Tumor
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
📍 Maryland Oncology Hematology — Calverton, Maryland
EGFR Mutation Positive Non-small Cell Lung Cancer
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Study of NXP900 With Lorlatinib in ALK+ Lung Cancer
📍 NEXT Virginia — Fairfax, Virginia
ALK Positive
View Study & Checklist ➔